-+ 0.00%
-+ 0.00%
-+ 0.00%

Scotiabank Initiates Coverage On Arcturus Therapeutics with Sector Outperform Rating, Announces Price Target of $32

Benzinga·05/28/2025 16:19:28
Listen to the news
Scotiabank analyst Greg Harrison initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Sector Outperform rating and announces Price Target of $32.